Healthgrades ranks top 50 hospitals based on clinical outcomes

The annual report by Healthgrades listing the top 50 hospitals based solely on clinical outcomes has been released, and 22 states don’t have a single hospital which made the cut.

Nearly 4,500 acute care hospitals, with performance judged on 32 common conditions and procedures, along with “an evaluation of comparative outcomes in appendectomy and bariatric surgery using all-payer data provided by 18 states.” California had the most hospitals of any state, with eight hospitals making the top 50, followed by Michigan and Illinois.

Similar to past reports, Healthgrades emphasized the differences in outcomes at five-star ranked hospitals, saying patients had a 71 percent lower risk of dying and 65 percent lower risk of complications if treated at the highest-ranked hospitals than a facility rated one star in the same category.

“The Healthgrades analysis unequivocally shows that consumers need to educate themselves before any surgery and get the facts on their personal risk in order to improve the likelihood of a positive outcome," said Healthgrades’ chief strategy officer Evan Marks.

If all hospitals had performed up to the five-star standards between 2013 and 2015, the report said on average, more than 223,000 lives could have been saved.

The risk differed among common surgeries. For example, the report said patients having coronary artery bypass grafting (CABG) at a five-star hospital had a 86 percent lower risk of complications or dying over one-star hospital patients.

Along with the report, Healthgrades released a new risk assessment tool for patients called Risk IQ, which judges a patient’s personal risk for complications or death for six procedures: CABG, total knee replacement, hip replacement, bariatric surgery, hysterectomy and pacemaker procedures. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.